TRCT
OM icon

Tower Research Capital (TRC)’s Outset Medical OM Stock Holding History

Tower Research Capital (TRC)’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.6K Buy
7,721
+4,740
+159% +$19.4K ﹤0.01% 3179
2025
Q4 		$11.1K Buy
2,981
+1,479
+98% +$12.7K ﹤0.01% 3657
2025
Q3 		$21.2K Sell
1,502
-335
-18% -$5.22K ﹤0.01% 3260
2025
Q2 		$35.3K Buy
1,837
+1,823
+13,021% +$28.5K ﹤0.01% 3272
2025
Q1 		$155 Buy
+14
New +$167 ﹤0.01% 5004
2024
Q4 		– Sell
-568
Closed -$5.77K – 5913
2024
Q3 		$5.77K Sell
568
-1,152
-67% -$34.3K ﹤0.01% 4225
2024
Q2 		$99.3K Buy
1,720
+824
+92% +$40.4K ﹤0.01% 2585
2024
Q1 		$29.8K Buy
896
+133
+17% +$6.73K ﹤0.01% 2653
2023
Q4 		$61.9K Sell
763
-366
-32% -$29.8K ﹤0.01% 2987
2023
Q3 		$184K Buy
1,129
+1,061
+1,560% +$250K 0.01% 1487
2023
Q2 		$22.2K Buy
68
+10
+17% +$3.05K ﹤0.01% 3294
2023
Q1 		$16K Buy
58
+40
+222% +$14.7K ﹤0.01% 3726
2022
Q4 		$7K Sell
18
-183
-91% -$51.6K ﹤0.01% 4595
2022
Q3 		$48K Buy
201
+56
+39% +$15K ﹤0.01% 3193
2022
Q2 		$32K Buy
145
+104
+254% +$44.7K ﹤0.01% 3307
2022
Q1 		$28K Sell
41
-18
-31% -$10.8K ﹤0.01% 3227
2021
Q4 		$40K Sell
59
-179
-75% -$132K ﹤0.01% 2948
2021
Q3 		$177K Buy
238
+172
+261% +$117K ﹤0.01% 1927
2021
Q2 		$49K Sell
66
-19
-22% -$14.5K ﹤0.01% 3043
2021
Q1 		$69K Buy
85
+13
+18% +$10K ﹤0.01% 2864
2020
Q4 		$61K Buy
72
+39
+118% +$30.1K ﹤0.01% 2901
2020
Q3 		$25K Buy
+33
New +$27.1K ﹤0.01% 3792

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Tower Research Capital (TRC)'s OM Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Outset Medical (OM) stake by 159% in Q1 2026, buying an estimated $19.4K and bringing the position to 7,721 shares worth $29.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3179.

Tower Research Capital (TRC) first reported a position in OM in Q3 2020 and has held it in 22 quarters since. The position peaked at $184K in Q3 2023. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Tower Research Capital (TRC) held 7,721 shares of Outset Medical worth $29.6K as of Q1 2026.
  • Tower Research Capital (TRC) bought 4,740 Outset Medical shares in Q1 2026, an estimated $19.4K.
  • Outset Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3179 holding.
  • Tower Research Capital (TRC) first reported a position in Outset Medical in Q3 2020 and has held it in 22 quarters since.
  • Tower Research Capital (TRC)'s Outset Medical position peaked at $184K in Q3 2023.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.